Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Altimmune, Inc. (ALT)
Sector: Healthcare; Industry: Biotechnology

Altimmune, Inc., a clinical stage biopharmaceutical company, focused developing treatments for liver disease, immune modulating therapies, and vaccines. The company also develops veterinary product candidates.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-03-01 Hodges Philip Director Sell 6,000 $16.08 $96,480 No
2020-12-10 Schafer Klaus Director Buy 2,000 $11.99 $23,980 No
2020-12-01 Hodges Philip Director Sell 3,727 $12.51 $46,614 No
2020-11-12 Schafer Klaus Director Sell 10,150 $9.91 $100,586 No
2020-11-12 Pisano Wayne Director Sell 10,352 $9.90 $102,485 No
2020-11-12 Harris Matthew Scott Director Sell 4,015 $10.02 $40,230 No
2020-06-15 Venrock Healthcare Capital Partners III, L.P. 10%-Owner Buy 1,500,000 $7.54 $11,310,000 No
2020-05-28 Venrock Healthcare Capital Partners III, L.P. 10%-Owner Buy 1,303,636 $8.74 $11,395,493 No
2020-05-15 VELOCITY PHARMACEUTICAL HOLDINGS LLC 10%-Owner Sell 200,000 $4.79 $957,100 No
2019-09-05 Garg Vipin K President and CEO Buy 20,000 $2.10 $42,000 No
2018-10-09 Pisano Wayne Director Buy 2,000 $4.59 $9,180 No
2018-05-25 Enright William President and CEO Buy 1,300 $0.51 $660 No
2017-06-06 Roberts M Scot Chief Scientific Officer Buy 449 $4.42 $1,985 No
2017-12-29 SAYARE MITCHEL Director Buy 5,100 $1.95 $9,963 No
2017-12-29 SCHAFFER DERACE L Director Buy 97,410 $1.92 $187,450 No
2017-12-27 SCHAFFER DERACE L Director Buy 147,130 $1.76 $259,356 No
2017-12-07 SCHAFFER DERACE L Director Buy 23,745 $1.78 $42,304 No
2017-12-05 SCHAFFER DERACE L Director Buy 26,010 $1.79 $46,588 No
2017-11-30 SCHAFFER DERACE L Director Buy 33,315 $1.91 $63,639 No
2017-11-27 SCHAFFER DERACE L Director Buy 21,808 $2.03 $44,282 No
2017-11-21 SCHAFFER DERACE L Director Buy 18,331 $2.08 $38,215 No
2017-08-25 SCHAFFER DERACE L Director Buy 67,326 $2.25 $151,282 No
2017-08-23 Drutz David Director Buy 10,000 $2.21 $22,097 No
2017-08-23 SCHAFFER DERACE L Director Buy 50,000 $2.21 $110,263 No
2017-06-02 GILL JOHN Director Buy 1,000 $4.34 $4,344 No
2016-12-09 PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 10%-Owner Sell 1,354,632 $3.26 $4,411,696 No
2016-04-13 RICHMAN ERIC I Director Sell 329,354 $2.20 $724,579 Yes
2016-04-08 RICHMAN ERIC I Director Sell 11,767 $2.20 $25,887 Yes
2015-03-19 St Peter Steven Director Buy 25,000 $1.65 $41,212 No
2015-01-07 CHANG LINDA L SVP, CFO & Secretary Sell 29,600 $2.10 $62,160 Yes

Insider Smart

Axsome Therapeutics, Inc (AXSM) - AXSM shows the power of an #allgreen stock, no insider selling, great management great company, if you follow the insiders last year and pick up around $25, the 52 week high is $100+.

Insider Smart

CEDAR FAIR L.P. (FUN) - Another crash victim, Cedar Fair L.P. took a deep dive from $54 to $13, insiders were confidence and eagerly jumped in around $27. With insiders on your side, this would be an easy add and hold to get your cost under $20. Stock is about to breach $40 in the coming weeks.